Lawrence E Samelson Selected Research

Oncogene Proteins (Oncogene Protein)

9/2007

Inhibition of T-cell receptor signal transduction and viral expression by the linker for activation of T cells-interacting p12(I) protein of human T-cell leukemia/lymphoma virus type 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lawrence E Samelson Research Topics

Disease

3	Neoplasms (Cancer) 01/2018 - 01/2015
1	Leukemia 01/2015
1	Lymphoma (Lymphomas) 01/2015
1	Disease Progression 01/2013
1	Infections 01/2013
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 09/2007
1	Autoimmune Diseases (Autoimmune Disease) 06/2002
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 06/2002

Drug/Important Bio-Agent (IBA)

2	MicroRNAs (MicroRNA)IBA 01/2015 - 01/2013
2	CalciumIBA 01/2013 - 09/2007
1	CytokinesIBA 11/2015
1	Proteins (Proteins, Gene)FDA Link 09/2007
1	Protein Kinase CIBA 09/2007
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 09/2007
1	Tetradecanoylphorbol AcetateIBA 09/2007
1	Oncogene Proteins (Oncogene Protein)IBA 09/2007
1	Tyrosine (L-Tyrosine)FDA Link 06/2002

Therapy/Procedure

2	Immunotherapy 01/2018 - 11/2015